“Falsified medicines (the term 'falsified' is used to distinguish the issue from IP violations, so-called 'counterfeits') are a major threat to public health and safety. As falsifications become more sophisticated, the risk that falsified medicines reach patients in the EU increases every year. Falsified medicines represent a serious threat to global health and call for a comprehensive strategy both at European and international level. “Falsified medicines (the term 'falsified' is used to distinguish the issue from IP violations, so-called 'counterfeits') are a major threat to public health and safety. As falsifications become more sophisticated, the risk that falsified medicines reach patients in the EU increases every year. Falsified medicines represent a serious threat to global health and call for a comprehensive strategy both at European and international level.
Find out moreNews from the field of drug verification.
The EU Hub Public certificates and endpoints require an update. Please refer to the below diagram for all the needed information which will allow the technical teams and connection providers to plan ahead.
We would like to inform you that the Board of Directors of SOOL, in accordance with the relevant legislation (Article 31, paragraph 5 of the Delegated Regulation of the EU Commission 2016/161 of 2 October 2015), approved on 19 August 2022 the amount
Radi by sme Vás informovali o plánovanej odstávky systému z dôvodu výmeny EU-HUB certifikátu, ktorý zabezpečuje prepojenie NMVS s EU-HUB-om.